Diabetisk retinopati

Jakob Grauslund; Nis Andersen; Jens Andresen; Toke Bek; Sara Brandi; Javad Hajari; Søren Tang Knudsen; Caroline Schmidt Laugesen; Majbrit Lind; Mette Slot Nielsen; Katja Schielke; Yousif Subhi

doi:10.61409/V04240246

Diabetisk retinopati

Jakob Grauslund^*
, Nis Andersen
, Jens Andresen
, Toke Bek
, Sara Brandi
, Javad Hajari
, Søren Tang Knudsen
, Caroline Schmidt Laugesen
, Majbrit Lind
, Mette Slot Nielsen
, Katja Schielke
, Yousif Subhi

^*Corresponding author af dette arbejde

Øjenafdelingen

Publikation: Bidrag til tidsskrift › Review › Forskning › peer review

Abstract

Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.

Bidragets oversatte titel	Diabetic retinopathy
Originalsprog	Dansk
Artikelnummer	V04240246
Antal sider	9
Tidsskrift	Ugeskrift for laeger
Vol/bind	186
Udgave nummer	37
DOI	https://doi.org/10.61409/V04240246
Status	Udgivet - 9 sep. 2024

Emneord

Diabetic Retinopathy/diagnosis
Humans
Denmark
Practice Guidelines as Topic
Mass Screening
Vitrectomy
Macular Edema/therapy

Adgang til dokumentet

10.61409/V04240246Licens: CC BY-NC-ND

Citationsformater

@article{1cff62fea2c34cdbbaedcfebe0aa87b2,

title = "Diabetisk retinopati",

abstract = "Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.",

keywords = "Diabetic Retinopathy/diagnosis, Humans, Denmark, Practice Guidelines as Topic, Mass Screening, Vitrectomy, Macular Edema/therapy",

author = "Jakob Grauslund and Nis Andersen and Jens Andresen and Toke Bek and Sara Brandi and Javad Hajari and Knudsen, \{S{\o}ren Tang\} and Laugesen, \{Caroline Schmidt\} and Majbrit Lind and Nielsen, \{Mette Slot\} and Katja Schielke and Yousif Subhi",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2024",

month = sep,

day = "9",

doi = "10.61409/V04240246",

language = "Dansk",

volume = "186",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "37",

}

TY - JOUR

T1 - Diabetisk retinopati

AU - Grauslund, Jakob

AU - Andersen, Nis

AU - Andresen, Jens

AU - Bek, Toke

AU - Brandi, Sara

AU - Hajari, Javad

AU - Knudsen, Søren Tang

AU - Laugesen, Caroline Schmidt

AU - Lind, Majbrit

AU - Nielsen, Mette Slot

AU - Schielke, Katja

AU - Subhi, Yousif

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2024/9/9

Y1 - 2024/9/9

N2 - Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.

AB - Diabetic retinopathy (DR) is the most common complication in patients with diabetes, and screening for sight-threatening end-stages is indicated to avoid severe visual loss. Screening of DR is nationally implemented in Denmark according to evidence-based national guidelines, which includes the use of individualised screening intervals. Treatment is indicated for proliferative DR and diabetic macular oedema, and treatment modalities include retinal laser therapy, intravitreal angiostatic therapy, and vitrectomy. In this review, we summarise the current guidelines for screening and treatment of DR in Denmark.

KW - Diabetic Retinopathy/diagnosis

KW - Humans

KW - Denmark

KW - Practice Guidelines as Topic

KW - Mass Screening

KW - Vitrectomy

KW - Macular Edema/therapy

U2 - 10.61409/V04240246

DO - 10.61409/V04240246

M3 - Review

C2 - 39323249

SN - 0041-5782

VL - 186

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

IS - 37

M1 - V04240246

ER -

Diabetisk retinopati

Abstract

Emneord

Adgang til dokumentet

Fingeraftryk

Citationsformater